Glucocorticoid receptor modulation [49] and neuronal calcium channel and glycogen synthase kinase-3 beta (GSK-3 beta) modulation targeting Alzheimer’s disease [50] have also been reported for ethanoanthracene derivatives. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.